Work

Phase I multicenter trial of CUDC-907 in children and young adults with relapsed/refractory solid tumors, CNS tumors, and lymphomas.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.10542

Authors: David Stephen Shulman, Cecilia Carlowicz, Clay Gustafson, Kieuhoa Tran Vo, Elizabeth Fox, Jodi Ann Muscal, Jeffrey G. Supko, Andrew E. Place, Susan N. Chi, Suzanne Shusterman, Gina Hanna, Jane O'Brien, Suzanne Ezrre, Pei-Chi Kao, Wendy B. London, Steven G. DuBois

Institutions: Boston Children's Hospital, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, University of California, San Francisco, Children's Hospital of Philadelphia, Baylor College of Medicine, Texas Children's Hospital, Massachusetts General Hospital

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4235369467

Cites:

Cited by: 5

Related to: 10